McGuireWoods provides strategic navigation of U.S. Food and Drug Administration (FDA) oversight. Our mission is to solve problems efficiently, add value, and implement strategies that help our clients reach their goals in a timely manner. The FDA and Life Sciences teams at McGuireWoods include two former members of the FDA and National Institutes of Health (NIH) and various lawyers active in the drugs (human and animal), biologics, medical devices, foods, beverages, dietary supplements, tobacco products, and cosmetics, and consumer product industries. By maintaining a positive relationship with the FDA and the other enforcement agencies, our team is able to keep clients informed on changes to regulatory policies and procedures and develop creative solutions to our clients’ needs and issues.
Our FDA & Life Sciences teams are multidisciplinary in structure and span many of our offices throughout the United States and Europe. Our team’s collective FDA-related experience and diverse skill set, allows us to navigate the FDA’s often complex and continually changing regulations and guidelines. We have counseled national and multinational manufacturers in all life science industries and are a full-service law firm with capabilities to meet any of our clients’ legal needs, including debt financing, venture capital funding, partnership agreements, distribution agreements, advertising and promotion, product liability considerations, and more.
Regulatory policies walk hand in hand with legislative mandates. In conjunction with our full-service public affairs subsidiary, McGuireWoods Consulting, we provide strategic communications and government relations guidance that helps businesses and industry coalitions shape pending legislation and respond to state and federal initiatives.